Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)

Why is Amazon cutting corporate jobs due to AI? How did Middle East tensions impact oil prices? What caused the recent plunge in solar stocks? Why did At Home file for bankruptcy? How will Kraft Heinz’s dye removal affect products? Why is the Senate passing a stablecoin regulation bill? What’s behind JPMorgan’s Sapphire Reserve fee hike?

Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)

finance.yahoo.com/news/roche-phase-3-move-boosts-173006521.html

In This Article:
Prothena Corporation plc (NASDAQ:PRTA) is among the best NASDAQ stocks under $50 to buy. Roche, a partner of Prothena Corporation plc (NASDAQ:PRTA), has announced plans to initiate Phase 3 development of prasinezumab for early-stage Parkinson’s disease. Although the…

This story appeared on finance.yahoo.com, 2025-06-17 17:30:06.